Hiroaki Ono

994 total citations
47 papers, 748 citations indexed

About

Hiroaki Ono is a scholar working on Clinical Biochemistry, Pediatrics, Perinatology and Child Health and Molecular Biology. According to data from OpenAlex, Hiroaki Ono has authored 47 papers receiving a total of 748 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Clinical Biochemistry, 16 papers in Pediatrics, Perinatology and Child Health and 13 papers in Molecular Biology. Recurrent topics in Hiroaki Ono's work include Metabolism and Genetic Disorders (18 papers), Folate and B Vitamins Research (11 papers) and Neonatal Health and Biochemistry (9 papers). Hiroaki Ono is often cited by papers focused on Metabolism and Genetic Disorders (18 papers), Folate and B Vitamins Research (11 papers) and Neonatal Health and Biochemistry (9 papers). Hiroaki Ono collaborates with scholars based in Japan, United States and United Kingdom. Hiroaki Ono's co-authors include Nobuo Sakura, Akiko Sakamoto, Takaatsu Eguchi, Go Tajima, Kazuhiro Ueda, Yoshihiro Tadori, Masao Kobayashi, Yutaka Nishimura, Hironobu Ichikawa and Naoto Fujita and has published in prestigious journals such as Blood, Molecular Therapy and Clinica Chimica Acta.

In The Last Decade

Hiroaki Ono

47 papers receiving 718 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hiroaki Ono Japan 17 222 198 189 174 141 47 748
Anna‐Kaisa Niemi United States 14 159 0.7× 238 1.2× 501 2.7× 74 0.4× 33 0.2× 27 1.1k
Miyoko Saito Japan 16 110 0.5× 31 0.2× 125 0.7× 25 0.1× 84 0.6× 58 712
Atsuko Noguchi Japan 15 30 0.1× 112 0.6× 163 0.9× 49 0.3× 22 0.2× 53 573
Dariusz Rokicki Poland 17 70 0.3× 254 1.3× 473 2.5× 99 0.6× 20 0.1× 66 868
S. Higuchi Japan 14 105 0.5× 35 0.2× 335 1.8× 41 0.2× 50 0.4× 22 977
Doris A. Trauner United States 12 61 0.3× 366 1.8× 268 1.4× 38 0.2× 56 0.4× 24 662
N. Jović Serbia 14 340 1.5× 52 0.3× 158 0.8× 241 1.4× 434 3.1× 51 935
S. Ho Hong Kong 18 299 1.3× 13 0.1× 132 0.7× 29 0.2× 530 3.8× 30 1.4k
Amy Goldstein United States 15 89 0.4× 532 2.7× 779 4.1× 59 0.3× 28 0.2× 29 1.1k
Wen‐Neng Chang Taiwan 16 228 1.0× 58 0.3× 199 1.1× 57 0.3× 264 1.9× 26 781

Countries citing papers authored by Hiroaki Ono

Since Specialization
Citations

This map shows the geographic impact of Hiroaki Ono's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hiroaki Ono with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hiroaki Ono more than expected).

Fields of papers citing papers by Hiroaki Ono

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hiroaki Ono. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hiroaki Ono. The network helps show where Hiroaki Ono may publish in the future.

Co-authorship network of co-authors of Hiroaki Ono

This figure shows the co-authorship network connecting the top 25 collaborators of Hiroaki Ono. A scholar is included among the top collaborators of Hiroaki Ono based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hiroaki Ono. Hiroaki Ono is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yamamoto, Shunsuke, Masafumi Sanefuji, Maya Suzuki, et al.. (2023). Pediatric leukemia and maternal occupational exposure to anticancer drugs: the Japan Environment and Children’s Study. Blood. 143(4). 311–319. 4 indexed citations
2.
Ono, Hiroaki, et al.. (2020). Novel LAMA2 variants identified in a patient with white matter abnormalities. Human Genome Variation. 7(1). 16–16. 2 indexed citations
3.
Fukai, Ryoko, Yasunari Sakai, Michiko Torio, et al.. (2016). De novo p.Arg756Cys mutation of ATP1A3 causes an atypical form of alternating hemiplegia of childhood with prolonged paralysis and choreoathetosis. BMC Neurology. 16(1). 174–174. 20 indexed citations
4.
Ichikawa, Hironobu, Katsunaka Mikami, Takashi Okada, et al.. (2016). Aripiprazole in the Treatment of Irritability in Children and Adolescents with Autism Spectrum Disorder in Japan: A Randomized, Double-blind, Placebo-controlled Study. Child Psychiatry & Human Development. 48(5). 796–806. 62 indexed citations
5.
Ohta, Toshiyuki, Yoshihiro Tada, Keita Matsubara, et al.. (2014). Eculizumab in the treatment of atypical hemolytic uremic syndrome in an infant leads to cessation of peritoneal dialysis and improvement of severe hypertension. Pediatric Nephrology. 30(4). 603–608. 15 indexed citations
6.
Sakano, Takashi, et al.. (2011). An infant with rotavirus infection presenting as a severe acute duodenal ulcer. Pediatrics International. 53(1). 100–101. 5 indexed citations
7.
Ono, Hiroaki, et al.. (2009). A case of carbamoyl phosphate synthetase 1 deficiency presenting symptoms at one month of age. Brain and Development. 31(10). 779–781. 16 indexed citations
9.
Sakano, Takashi, Tetsuo Nakayama, Y. Okada, et al.. (2008). Neonatal pertussis presenting as acute bronchiolitis: direct detection of the Bordetella pertussis genome using loop-mediated isothermal amplification. European Journal of Pediatrics. 168(3). 347–349. 11 indexed citations
10.
Sakamoto, Akiko, et al.. (2004). Determination of total homocysteine in dried blood spots using high performance liquid chromatography for homocystinuria newborn screening. Pediatrics International. 46(1). 5–9. 18 indexed citations
12.
Ono, Hiroaki, et al.. (2002). The C677T mutation in the methylenetetrahydrofolate reductase gene contributes to hyperhomocysteinemia in patients taking anticonvulsants. Brain and Development. 24(4). 223–226. 42 indexed citations
13.
Taka, Tomomi, Hiroaki Ono, Yasuto Sasaki, Junji Seki, & Junichiro Yamamoto. (2002). Platelet reactivity in spontaneously diabetic rats is independent from blood glucose and insulin levels. Platelets. 13(5-6). 313–316. 11 indexed citations
14.
Ono, Hiroaki, et al.. (2002). Cerebral Thrombosis And Microcirculation Of The Rat During The Oestrous Cycle And After Ovariectomy. Clinical and Experimental Pharmacology and Physiology. 29(1-2). 73–78. 16 indexed citations
15.
Ono, Hiroaki, et al.. (2001). Plasma total glutathione concentrations in healthy pediatric and adult subjects. Clinica Chimica Acta. 312(1-2). 227–229. 48 indexed citations
16.
Sakamoto, Akiko, et al.. (2001). Betaine and homocysteine concentrations in infant formulae and breast milk. Pediatrics International. 43(6). 637–640. 14 indexed citations
17.
Ono, Hiroaki, Akiko Sakamoto, & Nobuo Sakura. (2000). Plasma total glutathione concentrations in epileptic patients taking anticonvulsants. Clinica Chimica Acta. 298(1-2). 135–143. 55 indexed citations
18.
Ono, Hiroaki, et al.. (2000). Delay of liver maturation as a cause of transient neonatal galactosemia. Pediatrics International. 42(1). 61–63. 5 indexed citations
19.
Sakura, Nobuo, et al.. (1998). Betaine dose and treatment intervals in therapy for homocystinuria due to 5,10‐methylenetetrahydrofolate reductase deficiency. Journal of Inherited Metabolic Disease. 21(1). 84–85. 20 indexed citations
20.
Sakura, Nobuo, et al.. (1997). Elevated plasma bile acids in hypergalactosaemic neonates: a diagnostic clue to portosystemic shunts. European Journal of Pediatrics. 156(9). 716–718. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026